Immunisations among school leavers: Is there a place for measles-mumps-rubella vaccine?

Eurosurveillance

Volumn 15, Issue 17, 2010, Pages 32-34

  Lashkari, H P ^a   El Bashir, H ^a  

^a ST ANN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ARTICLE; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; IMMUNITY; IMMUNIZATION; MALE; QUESTIONNAIRE; SCHOOL HEALTH SERVICE; DRUG TOXICITY; MASS IMMUNIZATION; RISK ASSESSMENT; RISK FACTOR; STATISTICS; STUDENT; UNITED KINGDOM; UTILIZATION REVIEW;

ADOLESCENT; DRUG TOXICITY; FEMALE; HUMANS; LONDON; MALE; MASS VACCINATION; MEASLES-MUMPS-RUBELLA VACCINE; RISK ASSESSMENT; RISK FACTORS; STUDENTS;

EID: 77952695426     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.17.19555-en     Document Type: Article

References (19)

1. Salisbury D, Ramsay M, Noakes K, editors. Immunisation against infectious disease, 2006; 3rd ed. Department of Health, London: chapter 21, 23, 28.
2. Department of Health. Health and social care information centre, NHS Immunisation Statistics, England: 2004-2005. Available from: http://www.dh.gov.uk/assetRoot/04/11/96/50/04119650.pdf
3. Health Protection Agency. Mumps Notifications, by Age group, 1989-2007. [Internet]. Available from: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733844620?p=1191942172913
4. Health Protection Agency. Confirmed cases of measles by region and age: 1996 -2007. [Internet]. Available from: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733778332
5. Paunio M, Peltola H, Valle M, Davidkin I, Virtanen M, Heinonen OP. Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine: J Epidemiol Community Health. 1999;53(3):173-8.
6. Morse D, O'Shea M, Hamilton G, Soltanpoor N, Leece G, Miller E, et al. Outbreak of measles in a teenage school population: the need to immunize susceptible adolescents, Epidemiol Infect. 1994:113(2):355-65.
7. Plotkin SA, Orenstein WA. Vaccines, 2004, 4th ed, Philadelphia, WB Saunders Company: Chapter 19-20.
8. Harling R, White JM, Ramsay ME, et al. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine. 2005;23(31):4070-4.
9. Health Protection Agency (HPA). Confirmed cases of Measles, Mumps and Rubella 1996-2008. Available from: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1195733833790
10. Health Protection Agency (HPA). Vaccination coverage statistics for children up to five years of age in the United Kingdom. Immunisation. Commun Dis Rep CDR Wkly 2004;14(4). [Internet]. Available from: http://www.hpa.org.uk/cdr/pages/immunisation.htm#COVER_jul_sep
11. Tookey P. Rubella in Scotland, Wales and England. Euro Surveill. 2004;9(4). pii=464. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=464
12. Hinman AR, Irons B, Lewis M, Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ. 2002; 80(4):264-70.
13. Miller E, Hill A, Morgan-Capner P, Forsey T, Rush M. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines. Vaccine. 1995;13(9):799-802.
14. Eaton L. Measles cases in England and Wales rise sharply in 2008 BMJ. 2009;338:b533, doi: 10.1136/bmj.b533.
15. Cohen C, White JM, Savage EJ, Gynn JR, Choi Y, Andrews N. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis. 2007:13(1):12-7.
16. Conly JM, Johnston B. Is mumps making a comeback? Can J infect Dis Med Microbiol. 2007;18(1):7-9.
17. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ. 2006;175(5):483-8.
18. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-9.
19. Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197(12):1662-8.